MK1986-014-1022: A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Oral and IV TedizolidPhosphate (MK-1986) in Inpatients Under 2 Years Old

Project: Research project

Project Details

StatusActive
Effective start/end date11/20/18 → 8/31/50

Funding

  • Merck Sharp & Dohme Corp